Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Liver Diseases Patients”

Showing 20 of 0 results

Not applicableEnded earlyNCT00286663
What this trial is testing

Autoimmune Hepatitis Study

Who this might be right for
Hepatitis, Autoimmune
University of Rochester 100
Post-approval studies (Phase 4)Ended earlyNCT00456248
What this trial is testing

Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin

Who this might be right for
Hepatitis C
Kadmon Corporation, LLC 5
Not applicableEnded earlyNCT01639547
What this trial is testing

Sustained Virological Response (SVR)Rate of Pegasys Plus Ribavirin in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Chang Gung Memorial Hospital 410
Not applicableStudy completedNCT01581554
What this trial is testing

Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B e Antigen PositiveChronic Hepatitis B e Antigen Negative
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 15
Large-scale testing (Phase 3)Study completedNCT01292239
What this trial is testing

A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 183
Not applicableStudy completedNCT01280656
What this trial is testing

A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 660
Not applicableStudy completedNCT06855056
What this trial is testing

Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis

Who this might be right for
Liver CirrhosisDecompensated Cirrhosis of Liver
European Foundation for Study of Chronic Liver Failure 189
Not applicableLooking for participantsNCT07329036
What this trial is testing

ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF

Who this might be right for
Acute Liver Failure
Institute for Clinical and Experimental Medicine 25
Not applicableStudy completedNCT02951364
What this trial is testing

Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea

Who this might be right for
Hepatitis C Virus
Gilead Sciences 1,081
Not applicableUnknownNCT00804752
What this trial is testing

Vitamin D Treatment in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Hillel Yaffe Medical Center
Not applicableStudy completedNCT01323452
What this trial is testing

Entecavir for Chronic Hepatitis B

Who this might be right for
Entecavir for Chronic Hepatitis B Patients
Foundation for Liver Research 418
Not applicableWithdrawnNCT00424684
What this trial is testing

Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation

Who this might be right for
Chronic Liver DiseaseTB
University of Pittsburgh
Not applicableUnknownNCT05812612
What this trial is testing

UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver Disease

Who this might be right for
COVID-19 Infection
Beijing Ditan Hospital 2,000
Not applicableUnknownNCT01677871
What this trial is testing

Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease

Who this might be right for
Chronic Liver Disease With Tuberclosis
Institute of Liver and Biliary Sciences, India 120
Not applicableUnknownNCT04650828
What this trial is testing

TDF Combined With LDT for the Treatment of HBeAg-positive Hepatitis B Patients With Poor Response to TDF for 12 Months

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 200
Testing effectiveness (Phase 2)Study completedNCT04099407
What this trial is testing

Pirfenidone and Advanced Liver Fibrosis.

Who this might be right for
Liver FibrosisChronic Liver Disease
Grupo Mexicano para el Estudios de las Enfermedades Hepaticas 122
Testing effectiveness (Phase 2)Study completedNCT01359644
What this trial is testing

Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 350
Post-approval studies (Phase 4)UnknownNCT02327702
What this trial is testing

Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, ChronicPregnancy
Asian-Pacific Alliance of Liver Disease, Beijing 200
Not applicableStudy completedNCT00724854
What this trial is testing

Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 1,146
Early research (Phase 1)Study completedNCT01453075
What this trial is testing

Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)

Who this might be right for
Chronic Hepatitis C Infection
VA Office of Research and Development 31
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation